# Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy

> **NCT03182153** · — · UNKNOWN · sponsor: **Atlantic Health System** · enrollment: 83 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DEVICE:** Extended Cardiac Monitoring

## Key facts

- **NCT ID:** NCT03182153
- **Lead sponsor:** Atlantic Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-12-28
- **Final completion:** 2018-12-31
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03182153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03182153, "Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03182153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*